About
Raphael Certain is the founder and CEO of Clarity, a French-American neurotechnology and healthcare startup focused on slowing neurodegenerative diseases such as Alzheimer's. He is also a named author on a 2025 Scientific Reports paper on VR-based gamma sensory stimulation, where he is affiliated with Clarity Health Technologies. Available sources portray him as an operating founder and scientific-commercial ecosystem participant rather than an investor or fund manager.
Areas of interest
neurotechnologydigital therapeuticsneurodegenerative diseaseAlzheimer's diseasevirtual reality therapeuticshealthcareclinical research